# Bristol-Myers Squibb Company (BMY) — Q3-2008 Earnings Results

**Report date:** 2008-10-23 (before market open)  
**Sector:** Health Care / Pharmaceuticals  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/BMY/earnings/Q3-2008

## Post-Earnings Brief

### Headline

Bristol Myers Squibb Beats on EPS, Stock Up 2.97%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.46 | N/A | +9.26% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management expressed confidence in their product pipeline and market position. They noted the importance of maintaining momentum in their therapeutic areas.

**Key quotes:**

> Management highlighted strong performance in key therapeutic areas.

> They emphasized ongoing commitment to research and development.

> There were no significant changes to their strategic priorities.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Bristol Myers Squibb's earnings report shows a positive surprise in EPS, which likely contributed to the stock's increase of nearly 3%. The lack of revenue data makes it difficult to assess overall performance, but management's optimistic tone suggests confidence in future growth. Investors may view the EPS beat as a sign of resilience in the company's core business areas.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/BMY/earnings/Q3-2008_